A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin
PHASE1CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
January 16, 2020
Primary Completion Date
March 13, 2023
Study Completion Date
March 13, 2023
Conditions
CancerSolid TumorCancer of Skin
Interventions
DRUG
2141 V-11
intratumoral injection of 2141-V11
Trial Locations (1)
10065
Rockefeller University, New York
All Listed Sponsors
lead
Rockefeller University
OTHER
NCT04059588 - A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin | Biotech Hunter | Biotech Hunter